ABT Stock Analysis & IQ Rating | Abbott Laboratories

ABT Price Performance

ABT Analysts opinion is negative and it remained unchanged from the past 3 months

Date

Action

Rating

Firm

Feb 01, 2026

Upgrade

Buy

Freedom Capital

Nov 20, 2025

Reiterate

Buy

BTIG

Oct 17, 2025

Reiterate

Outperform

Evercore ISI

Oct 17, 2025

Reiterate

Outperform

Raymond James

Oct 17, 2025

Reiterate

Outperform

RBC

Abbott (ABT) Faces Profit Headwinds as Pediatric Nutrition Remains Under Pressure. Abbott Laboratories (NYSE:ABT) is included among the Dividend Growth Stocks: 25 Aristocrats. A Reuters report said Abbott Laboratories (NYSE:ABT) warned that its current-quarter profit would come in below expectations after the company also fell short of Wall Streets revenue forecasts on January 22. Pressure has been building in Abbotts pediatric nutrition business which has struggled [….]

Tue Feb 3, 2026

Abbott: Long-Term Investment Opportunity For Dividend Growth Investors.

Mon Feb 2, 2026

The Best Dividend King to Buy With $150. Key PointsAbbott Labs fourth-quarter report was disappointing partly due to slow sales growth.

Mon Feb 2, 2026

Abbot (ABT) is a High Quality Company Says Jim Cramer. We recently published 14 Stocks on Jim Cramers Radar.  Abbott Laboratories (NYSE:ABT) is one of the stocks on Jim Cramer’.s radar. Pharma giant Abbott Laboratories (NYSE:ABT)s shares are down 15.9% over the past year and 12% year-to-date. The stock was dealt a hefty blow in January after the firm reported its fiscal fourth quarter earnings. [….]

Wed Jan 28, 2026

Greg Abbott Imposes Sweeping Ban On Texas Employees Using Products And Services From Alibaba Shein And Temu. On Monday Gov. In a statement Abbott said that Texas state employees are prohibited from using products and services from companies including BABA) and The reason cited is concerns that the Chinese government could gain access to sensitive data.The restriction applies to physical hardware software and artificial intelligence tools.The governor said the move is aimed at protecting the priv

Tue Jan 27, 2026

Evercore ISI Says Abbotts (ABT) Core Growth Drivers Are Still Intact. Abbott Laboratories (NYSE:ABT) is included among the 12 Most Profitable Dividend Stocks to Buy in 2026. On January 23 Evercore ISI trimmed its price target on Abbott Laboratories (NYSE:ABT) to $138 from $144. However it kept an Outperform rating. The firm acknowledged the recent stumbles that led to a quarterly miss and a more cautious [….]

Mon Jan 26, 2026

Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It. Zacks.com users have recently been watching Abbott (ABT) quite a bit. Thus it is worth knowing the facts that could determine the stocks prospects.

Mon Jan 26, 2026

Monday 1/26 Insider Buying Report: ABT ALLY. As the saying goes there are many possible reasons for an insider to sell a stock but only one reason to buy -- they expect to make money. So lets look at two noteworthy recent insider buys.At Abbott Laboratories a filing with the SEC revealed that on Friday CHAIRMAN AND

Mon Jan 26, 2026

3 Reasons to Buy This Dividend King After Its Steep Sell-Off. Key PointsAbbotts stock plunged after the company reported lower-than-expected Q4 revenue last week.

Mon Jan 26, 2026

Abbotts India Unit Under Scrutiny Due To Phensedyl Cough Syrup Supply Chain. Indian authorities are scrutinizing the supply chain of Abbott Healthcare halted production of Phensedyl in December 2024 citing persistent misuse despite safeguards. However the drug is reportedly active within existing supply channels.Regulators claim large volumes continue to circulate in the market raising concerns about non-therapeutic use and possible abuse.Phensedyl contains codeine a narcotic commonly used in b

Fri Jan 23, 2026